Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2010-08-02 (15 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CADOLIVE (13950), Bouches-du-Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE ROMANO : revenue, balance sheet and financial ratios
PHARMACIE ROMANO is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CADOLIVE (13950),
this company of category PME
shows in 2024 a revenue of 1.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE ROMANO (SIREN 524137478)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
1 806 471 €
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
144 494 €
123 809 €
107 495 €
115 209 €
94 214 €
54 332 €
39 882 €
67 460 €
75 745 €
53 199 €
EBITDA
N/C
187 460 €
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
6.9%
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE ROMANO generates positive net income of 144 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 53 k€ -> 144 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
144 494 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 5%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 77%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
4.993%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
76.731%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
279.139
181.768
124.537
97.802
68.241
40.433
24.364
8.394
14.673
4.993
Financial autonomy
22.785
30.496
37.657
42.258
49.119
59.177
66.747
77.074
73.063
76.731
Repayment capacity
None
None
None
None
None
None
None
None
0.849
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
6.98%
None%
Sector positioning
Debt ratio
4.992025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Excellent
In 2025, the debt ratio of PHARMACIE ROMANO (4.99) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
76.73%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Excellent
In 2025, the financial autonomy of PHARMACIE ROMANO (76.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.85 years2024
2024
Q1: 0.52 years
Med: 3.18 years
Q3: 7.6 years
Good
In 2024, the repayment capacity of PHARMACIE ROMANO (0.85) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 162.46. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
162.455
Liquidity indicators evolution PHARMACIE ROMANO
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
220.327
223.241
209.244
177.653
169.312
183.385
205.987
201.534
203.138
162.455
Interest coverage
None
None
None
None
None
None
None
None
4.077
None
Sector positioning
Liquidity ratio
162.462025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Average-14 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE ROMANO (162.46) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
4.08x2024
2024
Q1: 0.0x
Med: 2.34x
Q3: 7.73x
Good
In 2024, the interest coverage of PHARMACIE ROMANO (4.1x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE ROMANO
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
189 011 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
38
0
Customer payment term (days)
64
79
0
0
0
0
0
0
4
0
Supplier payment term (days)
547
493
0
0
0
0
0
0
31
0
Positioning of PHARMACIE ROMANO in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE ROMANO is estimated at
2 295 304 €
(range 1 557 604€ - 3 601 648€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1557k€2295k€3601k€
2 295 304 €Range: 1 557 604€ - 3 601 648€
NAF 5 année 2025
Valuation method used
Net Income Multiple
144 494 €
×
15.9x
=2 295 304 €
Range: 1 557 604€ - 3 601 649€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE ROMANO with other companies in the same sector:
The revenue of PHARMACIE ROMANO in 2024 is 1.8 M€.
Is PHARMACIE ROMANO profitable?
Yes, PHARMACIE ROMANO generated a net profit of 144 k€ in 2025.
Where is the headquarters of PHARMACIE ROMANO ?
The headquarters of PHARMACIE ROMANO is located in CADOLIVE (13950), in the department Bouches-du-Rhone.
Where to find the tax return of PHARMACIE ROMANO ?
The tax return of PHARMACIE ROMANO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE ROMANO operate?
PHARMACIE ROMANO operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart